Briviact Intravenous and Moxetumomab Pasudotox-tdfk
Determining the interaction of Briviact Intravenous and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brivaracetam
Brand name: Briviact
Synonyms: Briviact
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Briviact Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Briviact Intravenous-Moxifloxacin
- Briviact Intravenous-Moxifloxacin (Systemic)
- Briviact Intravenous-Moxifloxacin Hydrochloride
- Briviact Intravenous-Moxifloxacin Injection
- Briviact Intravenous-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Brodalumab
- Moxetumomab Pasudotox-tdfk-Brodalumab Subcutaneous
- Moxetumomab Pasudotox-tdfk-Brodspec
- Moxetumomab Pasudotox-tdfk-Brom Mal Phenyl HCl Dex HBr
- Moxetumomab Pasudotox-tdfk-Bromaline
- Moxetumomab Pasudotox-tdfk-Bromaline DM